Who Owns Aptevo Therapeutics Stock?
NASDAQ: APVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 2.88%
- Held by insiders
- 4.15%
- Institutional holders
- 11
- Institutions 2.9%
- Insiders 4.2%
- Public and other 93.0%
Who owns Aptevo Therapeutics stock?
Institutional investors own about 2.9% of Aptevo Therapeutics's shares, spread across 11 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 4.15% of APVO.
The largest institutional holders are GSA Capital Partners LLP (1.19%), Vanguard Capital Management LLC (0.70%) and Geode Capital Management, LLC (0.60%). Together, the top 10 institutions control 2.8% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their APVO positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of APVO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| GSA Capital Partners LLP | 21.54K | 1.19% | +9.7% |
| Vanguard Capital Management LLC | 12.71K | 0.70% | 0.0% |
| Geode Capital Management, LLC | 10.82K | 0.60% | -18.9% |
| Vanguard Fiduciary Trust Co | 4.14K | 0.23% | 0.0% |
| UBS Group AG | 730 | 0.04% | -78.8% |
| Osaic Holdings Inc. | 360 | 0.02% | 0.0% |
| SBI Securities Co., Ltd. | 109 | 0.01% | 0.0% |
| Barclays Plc | 31 | 0.00% | +100.0% |
| CWM, LLC | 5 | 0.00% | -16.7% |
| Danske Bank A/s | 1 | 0.00% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of APVO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 12.71K | 0.70% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 6.38K | 0.35% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 1.55K | 0.09% |
Frequently asked questions
Who is the largest shareholder of Aptevo Therapeutics?
GSA Capital Partners LLP is the largest institutional shareholder of APVO, owning 1.19% of shares outstanding (21.54K shares) as of its latest 13F filing.
What percentage of Aptevo Therapeutics is owned by institutions?
Institutions own about 2.9% of APVO shares and 3.0% of the public float.
How much of Aptevo Therapeutics do insiders own?
Insiders, such as officers and directors, own about 4.15% of APVO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.